Regulator

Summary of regulator annotations and link-out to annotation databases

Basic gene annotations are collected from Uniprot and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser is available.

REL - REL proto-oncogene, NF-kB subunit

Function

Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The NF-kappa-B heterodimer RELA/p65-c-Rel is a transcriptional activator.

Uniprot Browser
Entrez IDEnsEMBL IDPreferred NameUniprot ID
5966 ENSG00000162924 REL Q04864

List of causal flows containing the regulator.

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulonthat contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows with ENSG00000162924 as Regulator

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-02329ERGup-regulatesRELactivatesR-24882Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-04003DSPup-regulatesRELactivatesR-24682Drugs (63)
CMF-06058OTOAdown-regulatesRELactivatesR-25282Drugs (17)
CMF-06346MATN4down-regulatesRELactivatesR-25283Drugs (17)
CMF-08302KIF4Adown-regulatesRELactivatesR-24684Drugs (63)
CMF-08303KIF4Adown-regulatesRELactivatesR-25284Drugs (17)
CMF-08304KIF4Adown-regulatesRELactivatesR-24884Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-08937DIAPH2down-regulatesRELactivatesR-24682Drugs (63)
CMF-10889SMARCA2up-regulatesRELactivatesR-24683Drugs (63)
CMF-10890SMARCA2up-regulatesRELactivatesR-25283Drugs (17)
CMF-11149MYO18Adown-regulatesRELactivatesR-24682Drugs (63)
CMF-12356GPR98down-regulatesRELactivatesR-24685Drugs (63)
CMF-12357GPR98down-regulatesRELactivatesR-25285Drugs (17)
CMF-13862ADAMTS8down-regulatesRELactivatesR-24686Drugs (63)
CMF-13863ADAMTS8down-regulatesRELactivatesR-25286Drugs (17)
CMF-13939HRH2up-regulatesRELactivatesR-25282Drugs (17)
CMF-13987CDKN2Cup-regulatesRELactivatesR-24683Drugs (63)
CMF-13988CDKN2Cup-regulatesRELactivatesR-25283Drugs (17)
CMF-16257USP11down-regulatesRELactivatesR-24883Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-16761CPNE8up-regulatesRELactivatesR-24681Drugs (63)
CMF-17172CDH18up-regulatesRELactivatesR-24881Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-17331SYNJ2up-regulatesRELactivatesR-24682Drugs (63)
CMF-17782C3down-regulatesRELactivatesR-25281Drugs (17)
CMF-19552NF1up-regulatesRELactivatesR-24687Drugs (63)
CMF-19553NF1up-regulatesRELactivatesR-25287Drugs (17)
CMF-19554NF1up-regulatesRELactivatesR-24887Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-23433MCOLN3down-regulatesRELactivatesR-24681Drugs (63)
CMF-28335EP400down-regulatesRELactivatesR-25281Drugs (17)
CMF-28447MYO9Bdown-regulatesRELactivatesR-25284Drugs (17)
CMF-28448MYO9Bdown-regulatesRELactivatesR-24884Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-28745SYN3down-regulatesRELactivatesR-24681Drugs (63)
CMF-29905DNAH2down-regulatesRELactivatesR-25281Drugs (17)
CMF-30496PROKR2down-regulatesRELactivatesR-24682Drugs (63)
CMF-30497PROKR2down-regulatesRELactivatesR-25282Drugs (17)
CMF-30668SALL4down-regulatesRELactivatesR-24684Drugs (63)
CMF-30669SALL4down-regulatesRELactivatesR-25284Drugs (17)
CMF-30715ABCA13down-regulatesRELactivatesR-24884Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-30759POLRMTup-regulatesRELactivatesR-24682Drugs (63)